Key result
Baseline log-transformed plasma NT-proBNP levels significantly predicted subsequent subclinical coronary atherosclerosis at 2 years (OR 2.71 per one-unit increase) among older Ugandan adults.
Why the study?
Cardiovascular disease phenotypes and mechanisms may differ globally, and distinct environmental determinants in sub-Saharan Africa may influence the development and progression of atherosclerotic coronary artery disease.
Does baseline NT-proBNP predict subsequent subclinical coronary atherosclerosis on CCTA in older Ugandan adults with cardiovascular risk factors?
Cohort (n=200)
Does baseline NT-proBNP predict subsequent subclinical coronary atherosclerosis on CCTA in older Ugandan adults with cardiovascular risk factors?
Baseline NT-proBNP independently predicts the presence of subclinical coronary atherosclerosis on CCTA at 2 years in a Ugandan cohort with cardiometabolic risk factors and HIV.
NT-proBNP predicted sCAD in Ugandan adults; extends biomarker role in SSA but leaves open mechanisms and practice change.
OBJECTIVE: Phenotypes and mechanisms of cardiovascular disease (CVD) may differ across global populations. In sub-Saharan Africa (SSA), distinct environmental determinants may influence development and progression of atherosclerotic coronary artery disease (CAD). METHODS: We investigated associations between 6 established markers of myocardial stress and subsequent subclinical CAD (sCAD), defined as presence of any atherosclerosis on coronary CT angiography (CCTA) in a 2-year prospective cohort of Ugandan adults enriched for cardiometabolic risk factors (RFs) and HIV. Six plasma biomarkers were measured baseline among 200 participants (50% with HIV) aged ≥ 45 years with ≥ 1 cardiovascular RF. At 2-year follow-up, 132 participants (52% with HIV) who returned underwent coronary CCTA. RESULTS: In logistic regression models adjusted for cardiovascular RFs (age, diabetes, hypertension, hyperlipidemia, smoking, obesity) and non-traditional RFs (HIV, chronic kidney disease), only NT-proBNP predicted subsequent subclinical CAD (p < 0.008, Bonferroni correction for multiple testing). In sensitivity analyses adjusted for ASCVD risk category (instead of individual RFs) in the baseline cohort with multiple imputation applied to missing year 2 CCTA data (n = 200), NT-proBNP remained significantly associated with subsequent CAD (p < 0.008). CONCLUSIONS: NT-proBNP consistently predicted subclinical CAD in Uganda in the absence of such an association among other markers of myocardial stress, suggesting a role for NT-proBNP in atherosclerosis independently of coronary microvascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Shakil et al. (2023) conducted a cohort in Subclinical coronary atherosclerosis (n=200). Log-transformed baseline plasma NT-proBNP was evaluated on Presence of subclinical coronary artery disease (detectable plaque on CCTA) (OR 2.71, 95% CI 1.39-5.95, p=0.006). Baseline log-transformed plasma NT-proBNP levels significantly predicted subsequent subclinical coronary atherosclerosis at 2 years (OR 2.71 per one-unit increase) among older Ugandan adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: